Who
Nicole Lemerond
Director
Company insider
Files Form 4 as: Director, MediciNova; Director, GeoVax Labs; Director, InMed Pharmaceuticals.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 10 Aug 2022
- Last trade
- 23 Jun 2026
- Last filed
- 25 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jun 2026filed 25 Jun 2026 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,500 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,500 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 19 Dec 2025filed 19 Dec 2025 | INM InMed Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,750 at $0.00 | filing |
| 17 Jun 2025filed 20 Jun 2025 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 5 Jun 2025filed 6 Jun 2025 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 12 Feb 2025filed 14 Feb 2025 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,500 at $0.00 | filing |
| 20 Dec 2024filed 23 Dec 2024 | INM InMed Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —550 at $0.00 | filing |
| 12 Aug 2024filed 14 Aug 2024 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,050 at $0.00 | filing |
| 11 Jun 2024filed 12 Jun 2024 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 23 Dec 2023filed 26 Dec 2023 | INM InMed Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,100 at $0.00 | filing |
| 4 Aug 2023filed 8 Aug 2023 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,333 at $0.00 | filing |
| 1 Aug 2023filed 14 Aug 2023 | GOVX GeoVax Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 16 Dec 2022filed 19 Dec 2022 | INM InMed Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —840 at $0.00 | filing |
| 10 Aug 2022filed 10 Aug 2022 | INM InMed Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.